Corza Medical

What Corza Medical does

Corza Medical is a global surgical medical device company founded in 2021 by Greg Lucier in partnership with private equity firm GTCR, operating across four business units: Biosurgery (anchored by the TachoSil fibrin sealant patch), Wound Closure (Quill barbed sutures and Sharpoint surgical sutures), Ophthalmology (Katena reusable instruments, Onatec sutures, Blink single-use instruments, SensorTek lenses, Barron devices), and Biomedical Textiles (Pearsalls precision textile manufacturing and the Innovation Lab in Taunton, UK). The company sells hemostatic patches, knot-free barbed sutures, ophthalmic microsurgical instruments, and biomedical textile components to surgeons, hospitals, ambulatory surgery centers, and OEM partners across more than 80 countries.

The company generates revenue through three primary streams: direct sales of proprietary surgical consumables and instruments (the majority of revenue), OEM and private-label biomedical textile manufacturing services, and reusable/single-use ophthalmic instrument sales via direct e-commerce and distribution partners. Pricing follows a B2B quote-based, multi-year contract model negotiated with hospitals, ASCs, and large medical supply distributors. Manufacturing is vertically integrated across seven global sites in the USA, Mexico, UK, Germany, and Austria, producing 150M+ meters of sutures and 2M+ hand-sewn devices annually; the July 2024 acquisition of Takeda's TachoSil manufacturing operations in Linz brought the flagship biosurgery product fully in-house.

Corza Medical employs more than 3,000 people globally and operates with a hybrid go-to-market model combining field-based sales representatives, two dedicated e-commerce storefronts (store.corza.com and corzaeye.com), and channel partners including Medline, which named the company Vendor of the Year 2026 in the alternate-site and acute-care space. The portfolio carries industry recognition including a #94 debut on the MedTech Big 100 and a #14 ranking on the Top 100 Healthcare Technology Companies of 2024. Recent strategic activity centers on ophthalmology expansion (Onatec portfolio of nearly 130 SKUs, SensorTek ROP Kit), the new Biomedical Textiles Innovation Lab, and the reaffirmation of the gut suture portfolio amid competitor exits.

Name

Corza Medical

Legal name

Corza Medical

Website

https://corza.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Corza Medical is a global surgical medical device company that provides hemostatic patches, barbed sutures, ophthalmic instruments, and biomedical textiles to surgeons, hospitals, ASCs, and OEM partners across more than 80 countries.

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115), Pharmaceutical Preparation Manufacturing (325412)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Ophthalmic Goods (3851), Pharmaceutical Preparations (2834)

akta.pro primary industry

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

akta.pro secondary industries

Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Oculoplastics & Lacrimal Surgical Devices (Ptosis/Orbital Tools, DCR/Lacrimal Stents, Facial Implants) (HLAHAJAL), Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics) (IMAOADAD), Surgical & Procedural Instruments (Scalpels, Forceps, Retractors) (HLAMAFAA)

Keywords

• Surgical medical devices
• Hemostatic patches
• Wound closure sutures
• Ophthalmic surgical instruments
• Biomedical textiles

Headquarters

HQ city

Boulder

HQ country

United States

HQ region

North America

Offices18 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Direct sales of proprietary surgical products including hemostatic patches, sutures, and ophthalmic instruments to healthcare providers, hospitals, and surgical centers.
2. OEM/Private Label Manufacturing: Custom biomedical textile manufacturing services for OEM partners including prototyping, testing, and scale-up support for textile-based medical components.
3. Instrument Sales: Sales of reusable and single-use ophthalmic instruments through direct e-commerce channels and distribution partners.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Corza Medical manufactures and sells surgical medical devices across four business units: Biosurgery (TachoSil fibrin sealant patches), Wound Closure (Quill barbed sutures and Sharpoint/Look sutures), Ophthalmology (Katena reusable instruments, Onatec sutures, SensorTek lenses, Blink single-use instruments), and Biomedical Textiles (Pearsalls precision textile manufacturing). The company also offers custom OEM/private label manufacturing for biomedical textile components.

Product overview

Corza Medical is a global medical technology company offering a platform of surgical essentials across four business units: Biosurgery (led by TachoSil fibrin sealant patch), Wound Closure (led by Quill barbed sutures and Sharpoint sutures), Ophthalmology (led by Katena reusable instruments, Onatec sutures, and SensorTek lenses), and Biomedical Textiles (led by Pearsalls precision textile manufacturing and the Innovation Lab). The company operates with over $500M in annual revenue, 3,000 employees, and manufacturing capabilities spanning seven global locations. The portfolio includes industry-leading brands such as Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Katena reusable and Blink single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint microsurgical knives, TachoSil fibrin sealant patch, and an expanded Onatec ophthalmic suture portfolio of approximately 130 products.

Differentiator

Problem solved

Functional benefit

Brands

• Quill: Barbed suture product line - time-saving closure device eliminating need for knots, featuring helical barbed design for secure wound closure
• Katena
• Onatec
• Blink
• TachoSil
• Sharpoint
• Look
• Pearsalls
• SensorTek
• Ambio
• Quill Veterinary

Products and services

• TachoSil Fibrin Sealant Patch Fibrin sealant patch consisting of human fibrinogen and human thrombin coated onto an equine collagen sponge, used as an adjunct to hemostasis in cardiovascular and hepatic surgery. Trusted in over 13 million applications globally.
• Quill Barbed Suture Knot-free closure device using helical barbed design to evenly distribute tension, reducing wound closure time by over 50% in some procedures. Available in bi-directional and uni-directional configurations with Monoderm, PDO, and polypropylene suture materials.
• Katena Reusable Instruments Portfolio of over 2,000 premium reusable ophthalmic surgical instruments including speculums, forceps, scissors, and CTAK instruments. Hand-crafted with high-quality stainless steel, precision honed for durability and reliability over decades of use.
• Onatec Ophthalmic Suture Portfolio Nearly 130-product ophthalmic suture portfolio designed solely for ophthalmic and oculoplastic surgery, featuring absorbable and non-absorbable sutures with highly tempered stainless steel needles for exceptional bending resistance and optimal geometry.
• SensorTek Diagnostic Lenses

Quantifiable outcome

• TachoSil: 81% lower probability of postoperative complications
• +7 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• European-African Hepato-Pancreato-Biliary Association (E-AHPBA)coreStrategic or Co-development Partner · 1 February 2025Three-year strategic partnership announced in February 2025 to advance HPB (Hepato-Pancreato-Biliary) surgical training and education. E-AHPBA will collaborate with Corza Medical to develop and deliver specialized training programs for HPB surgeons, supporting the advancement of surgical techniques and patient outcomes in liver, pancreas, and biliary tract surgeries.
• MedlinecoreChannel Partner/ Reseller/ DistributorMedline is a major medical supply distributor that recognized Corza Medical as Vendor of the Year 2026 in the Alternate-Site and Acute-Care Space. This recognition indicates Medline distributes Corza Medical products to healthcare facilities across alternate-site and acute-care settings.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Conmed: Conmed is a global medical device company focused on surgical and orthopedic solutions, with product lines in electrosurgery, suturing, and endoscopic technologies. Corza competes with Conmed in surgical specialties, particularly in wound closure and minimally invasive instrumentation.
• B. Braun Surgical: B. Braun is a major European-headquartered competitor in surgical sutures, wound closure, and ophthalmic surgical instruments. Corza competes directly with B. Braun's Suture and Aesculap divisions across multiple specialties and geographies, particularly in EMEA where both maintain strong direct sales footprints.
• Teleflex: Teleflex is a diversified medical technology company serving hospitals and surgical centers with sutures, ligation devices, and specialty surgical instruments. Corza competes with Teleflex in wound closure and surgical device categories, with similar enterprise sales models targeting surgical teams.
• Integra LifeSciences: Integra LifeSciences is a specialty medical device company with overlapping portfolios in surgical instruments, wound closure, and ophthalmic products. Corza competes with Integra in regenerative tissue technologies (Ambio amniotic membrane) and specialty surgical instruments, with similar mid-cap scale and private/public capital structures.
• CooperSurgical: CooperSurgical is a women's health and surgical device company offering wound closure, suturing, and specialty surgical solutions. Corza competes with CooperSurgical in dermatology, plastic surgery, and gynecology sutures, with overlapping customer bases in ambulatory surgery centers.
• Merit Medical Systems: Merit Medical is a specialty medical device company with surgical and interventional product lines including sutures, biosurgical products, and OEM manufacturing. Corza competes with Merit in surgical specialties and shares a similar strategy of building a portfolio through acquisitions of niche surgical brands.

Emerging players

• Surmodics: Surmodics is a smaller specialty medical device and in-vitro diagnostics company with selective overlap in surgical coatings and hemostasis-adjacent products. While smaller and more focused, Surmodics represents the type of niche strategic competitor that could intersect with Corza's biosurgery franchise.

Broad incumbents

• Ethicon (Johnson & Johnson): Ethicon is the global market leader in surgical sutures and wound closure, operating as part of Johnson & Johnson MedTech. It is Corza's primary direct competitor in sutures, with surgeon quotes explicitly citing Corza products as 'equivalent to Ethicon.' Both companies serve hospitals and ambulatory surgery centers with overlapping wound closure portfolios.
• Alcon: Alcon is the global leader in ophthalmic surgical devices and vision care, with a comprehensive portfolio including surgical instruments, sutures, and intraocular lenses. Corza's ophthalmology business (Katena, Onatec, SensorTek, Blink) competes with Alcon's surgical franchise in ophthalmic OR settings.
• Bausch + Lomb: Bausch + Lomb is a major ophthalmic medical device and pharmaceutical company with surgical instrument, suture, and IOL offerings. Corza's ophthalmology division competes with Bausch + Lomb in surgical instruments, sutures, and diagnostic lenses across both US and international markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/CorzaMedical
• Facebookfacebook.com/corzamedical
• LinkedInlinkedin.com/company/corzamedical
• Instagraminstagram.com/corzamedical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries4 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Corza Medical